SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-009299
Filing Date
2021-07-27
Accepted
2021-07-27 08:01:44
Documents
3
Period of Report
2021-07-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210723x8k.htm 8-K 32135
2 EX-99.1 tmb-20210723xex99d1.htm EX-99.1 13741
3 GRAPHIC tmb-20210723xex99d1001.jpg GRAPHIC 2995
  Complete submission text file 0001558370-21-009299.txt   51610
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 211115945
SIC: 2834 Pharmaceutical Preparations